Loading...
Keywords
Last Name
Institution

Rangaraj Selvarangan

Concepts (499)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Influenza, Human
25
2024
57
8.540
Why?
Enterovirus Infections
19
2023
37
8.120
Why?
Respiratory Tract Infections
21
2023
75
7.750
Why?
Parechovirus
15
2023
19
7.230
Why?
Picornaviridae Infections
14
2023
20
6.930
Why?
Molecular Diagnostic Techniques
15
2022
40
6.310
Why?
Influenza A virus
12
2023
20
5.720
Why?
Infant
87
2024
1449
5.620
Why?
Humans
156
2024
6797
5.540
Why?
Respiratory Syncytial Virus Infections
12
2023
41
5.010
Why?
Child
98
2024
3257
4.920
Why?
Influenza B virus
13
2023
22
4.770
Why?
Respiratory Syncytial Virus, Human
10
2023
23
4.530
Why?
Enterovirus
8
2023
12
4.420
Why?
Enterovirus D, Human
12
2023
25
4.310
Why?
Child, Preschool
74
2023
1503
4.200
Why?
Gastroenteritis
15
2023
25
4.020
Why?
Nucleic Acid Amplification Techniques
6
2020
13
3.720
Why?
Anti-Bacterial Agents
18
2023
244
3.150
Why?
Sensitivity and Specificity
29
2023
147
3.140
Why?
Disease Outbreaks
12
2023
30
3.060
Why?
Female
71
2024
3599
2.860
Why?
Male
67
2023
3328
2.830
Why?
United States
47
2024
656
2.770
Why?
Rotavirus Infections
12
2023
15
2.720
Why?
Adolescent
50
2024
2137
2.630
Why?
Rotavirus Vaccines
9
2023
13
2.630
Why?
Feces
18
2023
37
2.520
Why?
Real-Time Polymerase Chain Reaction
10
2023
41
2.460
Why?
Central Nervous System Infections
3
2021
5
2.430
Why?
Infant, Newborn
34
2023
828
2.430
Why?
Diagnostic Tests, Routine
5
2019
19
2.370
Why?
Rotavirus
9
2023
11
2.230
Why?
Nasopharynx
12
2023
25
2.210
Why?
Prospective Studies
27
2024
522
2.150
Why?
Antibodies, Viral
11
2022
46
2.090
Why?
Norovirus
5
2023
7
2.070
Why?
Bacteremia
5
2021
25
1.940
Why?
Streptococcal Infections
4
2020
19
1.920
Why?
Hospitalization
20
2024
194
1.900
Why?
Reverse Transcriptase Polymerase Chain Reaction
10
2020
84
1.810
Why?
Virus Diseases
3
2022
11
1.780
Why?
Reagent Kits, Diagnostic
9
2018
12
1.740
Why?
Virology
5
2015
5
1.590
Why?
Pneumonia, Mycoplasma
6
2024
15
1.550
Why?
Urinary Tract Infections
3
2021
21
1.550
Why?
Young Adult
19
2022
665
1.530
Why?
Influenza Vaccines
7
2024
24
1.470
Why?
Adult
24
2023
1259
1.450
Why?
Bacteriological Techniques
5
2021
7
1.420
Why?
DNA, Viral
4
2020
13
1.410
Why?
Point-of-Care Testing
2
2020
7
1.410
Why?
Sepsis
4
2018
22
1.370
Why?
Middle Aged
16
2021
651
1.320
Why?
Mycoplasma pneumoniae
5
2020
12
1.310
Why?
Aged
13
2021
376
1.290
Why?
Emergency Service, Hospital
7
2024
130
1.290
Why?
Retrospective Studies
20
2023
1332
1.270
Why?
Clostridium Infections
3
2020
7
1.270
Why?
Aged, 80 and over
10
2021
150
1.240
Why?
Enterobacteriaceae Infections
3
2023
10
1.230
Why?
Polymerase Chain Reaction
6
2019
88
1.230
Why?
Specimen Handling
5
2021
18
1.200
Why?
Drug Resistance, Multiple, Bacterial
4
2023
11
1.200
Why?
Staphylococcal Infections
4
2016
23
1.200
Why?
Enterobacteriaceae
3
2023
7
1.190
Why?
Staphylococcus aureus
3
2016
19
1.180
Why?
Respiratory System
3
2015
5
1.120
Why?
Cerebrospinal Fluid
4
2020
8
1.110
Why?
Immunoassay
4
2015
8
1.080
Why?
Escherichia coli
11
2023
28
1.080
Why?
Genotype
17
2022
401
1.070
Why?
Point-of-Care Systems
3
2020
15
1.060
Why?
Multiplex Polymerase Chain Reaction
3
2022
9
1.060
Why?
Influenza A Virus, H1N1 Subtype
5
2024
12
1.060
Why?
Cephalosporins
3
2023
16
1.060
Why?
Hematopoietic Stem Cell Transplantation
3
2020
51
1.050
Why?
Rhinovirus
4
2023
11
1.040
Why?
Antibodies, Neutralizing
5
2022
31
1.030
Why?
Microbial Sensitivity Tests
13
2023
32
1.030
Why?
Missouri
9
2023
78
1.020
Why?
Bodily Secretions
2
2015
3
1.020
Why?
Seasons
9
2023
27
1.000
Why?
Prevalence
12
2023
149
0.990
Why?
Caliciviridae Infections
3
2021
4
0.990
Why?
Streptococcus pyogenes
3
2020
13
0.970
Why?
Vancomycin Resistance
2
2014
4
0.920
Why?
Dysentery, Bacillary
1
2023
2
0.920
Why?
Shigella
1
2023
2
0.920
Why?
Pseudomonas Infections
1
2023
7
0.910
Why?
Cystic Fibrosis
1
2023
18
0.900
Why?
Inpatients
3
2020
45
0.890
Why?
Pandemics
8
2024
85
0.880
Why?
Coinfection
1
2022
5
0.870
Why?
Automation, Laboratory
2
2019
4
0.870
Why?
Population Surveillance
6
2021
12
0.870
Why?
Pharyngitis
2
2020
14
0.840
Why?
Viral Vaccines
3
2022
10
0.840
Why?
Itraconazole
2
2020
2
0.830
Why?
Triazoles
2
2020
3
0.830
Why?
Asthma
2
2023
143
0.810
Why?
Time Factors
8
2020
247
0.810
Why?
Clinical Laboratory Techniques
5
2021
9
0.810
Why?
Mass Screening
2
2019
41
0.800
Why?
Bacterial Infections
1
2021
27
0.800
Why?
Neurodevelopmental Disorders
1
2021
19
0.800
Why?
Phlebotomy
2
2011
2
0.780
Why?
Equipment Contamination
2
2011
6
0.780
Why?
Phylogeny
10
2022
21
0.780
Why?
Antiviral Agents
4
2021
26
0.770
Why?
Enterocolitis, Pseudomembranous
1
2020
4
0.760
Why?
Vaccination
12
2024
68
0.760
Why?
Asymptomatic Infections
1
2020
4
0.760
Why?
Antigens, Viral
4
2022
7
0.760
Why?
Kansas
4
2023
49
0.740
Why?
RNA Viruses
1
2019
3
0.730
Why?
Urinalysis
1
2019
6
0.720
Why?
Communicable Diseases, Emerging
1
2019
3
0.710
Why?
Central Nervous System Viral Diseases
1
2019
6
0.700
Why?
Peritonitis
2
2021
52
0.690
Why?
Drug Utilization
1
2018
13
0.680
Why?
Molecular Typing
1
2018
2
0.670
Why?
Respiratory Syncytial Viruses
2
2015
16
0.660
Why?
Paramyxoviridae Infections
2
2022
12
0.640
Why?
Risk Factors
8
2023
470
0.630
Why?
Bordetella Infections
2
2014
2
0.630
Why?
Bordetella parapertussis
2
2014
2
0.630
Why?
Peritoneal Dialysis
2
2021
148
0.630
Why?
Severity of Illness Index
6
2021
144
0.620
Why?
Escherichia coli Infections
7
2017
19
0.610
Why?
Carrier State
2
2018
5
0.600
Why?
Case-Control Studies
10
2024
205
0.600
Why?
Adhesins, Escherichia coli
9
2017
9
0.590
Why?
Methicillin-Resistant Staphylococcus aureus
5
2016
16
0.580
Why?
Fever
4
2021
27
0.570
Why?
Venous Thromboembolism
1
2015
10
0.550
Why?
Drug Resistance, Bacterial
5
2020
14
0.550
Why?
Sequence Analysis, DNA
7
2019
115
0.540
Why?
Herpes Simplex
2
2020
10
0.540
Why?
RNA, Viral
3
2015
16
0.530
Why?
Pharynx
3
2020
7
0.530
Why?
Mycoplasma
1
2015
2
0.530
Why?
Mycoplasma Infections
1
2015
2
0.530
Why?
Antigens, Bacterial
3
2011
9
0.520
Why?
Bordetella pertussis
1
2014
1
0.510
Why?
Spike Glycoprotein, Coronavirus
4
2022
19
0.510
Why?
Chromatography, Affinity
1
2014
2
0.510
Why?
Viruses
3
2022
5
0.500
Why?
Blood Specimen Collection
2
2011
4
0.500
Why?
Macrolides
5
2020
9
0.490
Why?
Animals
12
2022
664
0.490
Why?
Vancomycin
1
2014
17
0.480
Why?
Adenovirus Infections, Human
2
2011
3
0.480
Why?
Virus Cultivation
4
2015
4
0.480
Why?
Saliva
3
2023
10
0.480
Why?
Genetic Variation
3
2022
167
0.450
Why?
Vaccines
2
2023
17
0.450
Why?
Metapneumovirus
2
2022
12
0.450
Why?
Enterococcus
1
2012
3
0.430
Why?
Gram-Positive Bacterial Infections
1
2012
7
0.430
Why?
Paramyxoviridae
1
2011
1
0.430
Why?
Streptococcus bovis
1
2011
1
0.420
Why?
Meningitis, Bacterial
1
2011
4
0.420
Why?
Influenza A Virus, H3N2 Subtype
5
2023
11
0.410
Why?
Oligonucleotide Probes
2
2009
4
0.410
Why?
Campylobacter Infections
1
2011
2
0.410
Why?
False Positive Reactions
1
2011
4
0.410
Why?
Adenoviruses, Human
1
2011
1
0.410
Why?
Intensive Care Units, Pediatric
1
2011
10
0.400
Why?
Blood
1
2011
11
0.400
Why?
Catheterization, Peripheral
1
2011
5
0.400
Why?
Meningitis, Viral
2
2022
2
0.390
Why?
Follow-Up Studies
5
2021
327
0.390
Why?
Pediatric Nursing
1
2010
5
0.380
Why?
Infection Control
1
2010
7
0.380
Why?
Genotyping Techniques
2
2020
21
0.370
Why?
Epidemiological Monitoring
5
2021
6
0.350
Why?
Encephalitis, Viral
1
2009
1
0.350
Why?
Simplexvirus
1
2009
3
0.350
Why?
Haemophilus influenzae
1
2009
4
0.350
Why?
Streptococcus pneumoniae
1
2009
5
0.350
Why?
Antifungal Agents
2
2020
13
0.340
Why?
Mycobacterium
2
2010
2
0.340
Why?
Schools
3
2023
50
0.330
Why?
Predictive Value of Tests
4
2019
104
0.320
Why?
Pyelonephritis
3
2004
4
0.310
Why?
Reproducibility of Results
3
2012
201
0.300
Why?
beta-Lactamases
3
2018
6
0.290
Why?
Acute Disease
3
2022
71
0.280
Why?
Antibodies, Monoclonal
2
2022
23
0.270
Why?
Fucosyltransferases
2
2015
2
0.270
Why?
Algorithms
3
2020
106
0.270
Why?
Immunity, Humoral
2
2022
14
0.260
Why?
Cluster Analysis
4
2015
45
0.260
Why?
Immunization Programs
2
2019
6
0.260
Why?
Cross Infection
2
2017
12
0.260
Why?
Adhesins, Bacterial
1
2004
1
0.260
Why?
Collagen Type IV
1
2004
3
0.260
Why?
Escherichia coli Proteins
1
2004
3
0.260
Why?
Cephalosporin Resistance
3
2018
4
0.250
Why?
Candida
1
2003
2
0.240
Why?
Fimbriae, Bacterial
3
2001
3
0.240
Why?
Cytomegalovirus Infections
1
2023
3
0.230
Why?
Azithromycin
1
2023
5
0.230
Why?
Longitudinal Studies
2
2020
126
0.230
Why?
Penicillanic Acid
1
2023
2
0.230
Why?
Cohort Studies
3
2021
274
0.230
Why?
Pseudomonas aeruginosa
1
2023
7
0.230
Why?
Students
1
2023
45
0.230
Why?
Oseltamivir
2
2021
6
0.220
Why?
Coronavirus
1
2022
2
0.220
Why?
Viral Fusion Proteins
1
2022
4
0.220
Why?
Seroepidemiologic Studies
2
2019
3
0.220
Why?
Craniocerebral Trauma
1
2022
18
0.220
Why?
Midwestern United States
2
2013
43
0.210
Why?
Hospitals, Pediatric
3
2020
183
0.210
Why?
Child, Hospitalized
3
2022
27
0.210
Why?
Critical Care
3
2018
12
0.210
Why?
Herpesvirus 1, Cercopithecine
1
2021
2
0.210
Why?
Central Nervous System
1
2021
7
0.210
Why?
Nasal Mucosa
1
2021
8
0.210
Why?
Lung Diseases
1
2021
26
0.210
Why?
Risk Assessment
2
2020
137
0.200
Why?
Child Abuse
1
2022
47
0.200
Why?
Cloud Computing
1
2021
5
0.200
Why?
Disease Management
2
2018
36
0.200
Why?
Lymphadenitis
2
2013
3
0.200
Why?
Public Health Surveillance
1
2020
5
0.200
Why?
Klebsiella Infections
2
2017
3
0.190
Why?
ROC Curve
1
2020
18
0.190
Why?
Ambulatory Care Facilities
1
2021
38
0.190
Why?
Quebec
1
2020
4
0.190
Why?
Coronavirus Infections
1
2020
16
0.190
Why?
Guanine Nucleotide Exchange Factors
1
2020
2
0.190
Why?
Drug Resistance, Viral
1
2020
3
0.190
Why?
Pneumonia, Viral
1
2020
17
0.190
Why?
DNA, Bacterial
3
2011
5
0.190
Why?
Canada
1
2020
31
0.190
Why?
Mouth
1
2020
3
0.190
Why?
Herpesvirus 1, Human
1
2020
4
0.190
Why?
International Classification of Diseases
1
2020
8
0.190
Why?
Family Health
1
2020
14
0.190
Why?
Gastrointestinal Diseases
1
2021
55
0.190
Why?
Monitoring, Physiologic
1
2020
24
0.190
Why?
Postoperative Care
1
2020
30
0.190
Why?
Europe
1
2020
33
0.190
Why?
Early Diagnosis
1
2020
34
0.180
Why?
Immunoenzyme Techniques
1
2019
10
0.180
Why?
Age Distribution
1
2019
32
0.180
Why?
Prognosis
1
2020
213
0.180
Why?
Gonorrhea
2
2015
4
0.180
Why?
Molecular Epidemiology
3
2017
7
0.180
Why?
History, 21st Century
1
2019
5
0.180
Why?
Chronic Disease
3
2012
104
0.170
Why?
Diphtheria-Tetanus-Pertussis Vaccine
1
2019
3
0.170
Why?
Bacterial Typing Techniques
2
2016
4
0.170
Why?
Immunization Schedule
1
2019
7
0.170
Why?
Critical Pathways
1
2018
9
0.170
Why?
Hematologic Diseases
1
2018
4
0.170
Why?
Immunologic Deficiency Syndromes
1
2018
9
0.170
Why?
False Negative Reactions
1
2018
10
0.160
Why?
Vaccines, Attenuated
4
2022
8
0.160
Why?
Intestines
1
2018
26
0.160
Why?
Cytopathogenic Effect, Viral
1
2017
2
0.160
Why?
Sapovirus
1
2017
1
0.160
Why?
Cells, Cultured
1
2017
76
0.160
Why?
Cell Line
1
2017
80
0.160
Why?
Klebsiella pneumoniae
1
2017
2
0.150
Why?
Dose-Response Relationship, Drug
1
2017
95
0.150
Why?
Antibiotic Prophylaxis
1
2017
30
0.150
Why?
Practice Guidelines as Topic
1
2017
97
0.150
Why?
Staphylococcal Skin Infections
1
2016
3
0.150
Why?
Genetic Predisposition to Disease
2
2015
224
0.150
Why?
Clindamycin
1
2016
3
0.150
Why?
Length of Stay
2
2018
243
0.140
Why?
Neoplasms
1
2018
120
0.140
Why?
Cross-Sectional Studies
4
2023
319
0.140
Why?
Recombination, Genetic
1
2015
3
0.140
Why?
Virulence Factors
1
2015
5
0.140
Why?
C-Reactive Protein
1
2015
16
0.140
Why?
Hemoglobins
1
2015
26
0.140
Why?
Adenoviridae
2
2022
6
0.140
Why?
Chlamydia trachomatis
1
2015
2
0.130
Why?
Trichomonas Vaginitis
1
2015
2
0.130
Why?
Chlamydia Infections
1
2015
3
0.130
Why?
Dogs
1
2015
16
0.130
Why?
Equipment Failure
1
2015
9
0.130
Why?
DNA, Ribosomal
2
2011
3
0.130
Why?
RNA, Ribosomal, 16S
2
2011
7
0.130
Why?
Unnecessary Procedures
1
2015
16
0.130
Why?
Treatment Outcome
5
2018
667
0.130
Why?
Quality Improvement
1
2015
60
0.130
Why?
Age Factors
3
2021
215
0.120
Why?
Base Sequence
2
2004
85
0.120
Why?
Molecular Sequence Data
3
2015
67
0.120
Why?
Mice
3
2022
312
0.120
Why?
Tertiary Care Centers
1
2013
10
0.120
Why?
Incidence
2
2011
132
0.120
Why?
Viral Proteins
1
2013
8
0.120
Why?
Abscess
1
2013
11
0.120
Why?
Diarrhea
2
2011
18
0.110
Why?
Anti-Infective Agents
1
2013
21
0.110
Why?
Pneumococcal Infections
2
2011
6
0.110
Why?
HeLa Cells
5
2004
15
0.110
Why?
Costs and Cost Analysis
1
2012
6
0.110
Why?
Immunity, Cellular
2
2022
18
0.110
Why?
RNA, Messenger
2
2023
148
0.110
Why?
Epitopes
2
2022
19
0.110
Why?
Enterotoxins
1
2011
2
0.100
Why?
Exudates and Transudates
1
2011
1
0.100
Why?
Middle Ear Ventilation
1
2011
1
0.100
Why?
Campylobacter
1
2011
2
0.100
Why?
Communicable Diseases
1
2011
9
0.100
Why?
Serotyping
1
2011
1
0.100
Why?
Restriction Mapping
1
2011
5
0.100
Why?
Epidemiologic Methods
1
2011
2
0.100
Why?
Policy Making
1
2011
3
0.100
Why?
Immunocompromised Host
2
2020
7
0.100
Why?
Quality of Health Care
1
2010
13
0.090
Why?
Cost of Illness
2
2020
19
0.090
Why?
Pregnancy
4
2024
271
0.090
Why?
Linear Models
1
2010
55
0.090
Why?
Postoperative Complications
1
2011
194
0.090
Why?
Disease Models, Animal
3
2005
74
0.090
Why?
Databases, Factual
1
2010
106
0.090
Why?
Moraxellaceae Infections
1
2009
1
0.090
Why?
Haemophilus Infections
1
2009
5
0.090
Why?
Parents
2
2021
152
0.090
Why?
Bacterial Proteins
3
2017
8
0.090
Why?
Chromatography, High Pressure Liquid
2
2010
41
0.080
Why?
Mycobacterium avium-intracellulare Infection
1
2008
2
0.080
Why?
Mutation
3
2019
199
0.080
Why?
Biomarkers
2
2021
123
0.080
Why?
Virulence
2
2004
7
0.080
Why?
Mycobacterium Infections
1
2006
1
0.070
Why?
Mice, Inbred C3H
2
2004
6
0.070
Why?
Anemia, Sickle Cell
1
2006
17
0.070
Why?
Illinois
2
2015
4
0.070
Why?
Enzyme-Linked Immunosorbent Assay
2
2015
23
0.060
Why?
Antibodies, Bacterial
1
2024
8
0.060
Why?
Chromatography, Gas
1
2004
1
0.060
Why?
Fatty Acids
1
2004
4
0.060
Why?
Culture Media
1
2003
1
0.060
Why?
Candida glabrata
1
2003
1
0.060
Why?
Mycology
1
2003
2
0.060
Why?
Candida albicans
1
2003
3
0.060
Why?
Gene Amplification
1
2003
4
0.060
Why?
Cricetinae
2
2002
4
0.060
Why?
CHO Cells
2
2002
4
0.060
Why?
DNA, Fungal
1
2003
4
0.060
Why?
DNA Primers
1
2003
36
0.060
Why?
Kidney
1
2004
96
0.060
Why?
Mothers
1
2024
37
0.060
Why?
Acceleration
1
2023
4
0.060
Why?
Cytomegalovirus
1
2023
2
0.060
Why?
Cross-Over Studies
1
2023
32
0.060
Why?
Neonatal Screening
1
2023
7
0.060
Why?
Educational Status
1
2023
20
0.060
Why?
Antibody Affinity
1
2022
4
0.060
Why?
Phenotype
1
2004
244
0.060
Why?
CD8-Positive T-Lymphocytes
1
2022
14
0.060
Why?
Oxygen
1
2022
17
0.060
Why?
Vaccines, Synthetic
1
2022
9
0.060
Why?
Complement System Proteins
1
2002
5
0.060
Why?
Macaca nemestrina
1
2002
1
0.060
Why?
Trypanosoma cruzi
1
2002
2
0.060
Why?
Chagas Disease
1
2002
2
0.060
Why?
Hematoma, Subdural
1
2022
5
0.060
Why?
Microbiological Techniques
2
2015
5
0.050
Why?
Hospitals
1
2022
39
0.050
Why?
Operon
2
2001
2
0.050
Why?
Viral Load
1
2021
20
0.050
Why?
Receptors, Cell Surface
1
2001
6
0.050
Why?
Immunity, Innate
1
2021
16
0.050
Why?
Epitope Mapping
1
2021
7
0.050
Why?
Antibody Specificity
1
2021
8
0.050
Why?
Cross Reactions
1
2021
7
0.050
Why?
T-Lymphocytes
1
2021
32
0.050
Why?
Host-Pathogen Interactions
1
2021
8
0.050
Why?
Phosphoproteins
1
2021
12
0.050
Why?
Vaccine Potency
1
2021
7
0.050
Why?
Microtubules
2
1999
5
0.050
Why?
Bacteria
1
2021
9
0.050
Why?
Immunization
1
2021
23
0.050
Why?
Comorbidity
1
2021
64
0.050
Why?
Immunoglobulin G
1
2021
33
0.050
Why?
Neck
2
2013
5
0.050
Why?
Transcriptome
1
2021
52
0.050
Why?
Dialysis Solutions
1
2021
19
0.050
Why?
Catheters, Indwelling
1
2021
30
0.050
Why?
Catheterization
1
2021
27
0.050
Why?
Self Care
1
2021
24
0.050
Why?
Skin
1
2020
13
0.050
Why?
Family Characteristics
1
2020
10
0.050
Why?
Vacuoles
1
2000
1
0.050
Why?
Glycosylphosphatidylinositols
1
2000
1
0.050
Why?
Interviews as Topic
1
2020
36
0.050
Why?
Liver
1
2021
139
0.050
Why?
RNA, Ribosomal, 23S
1
2019
1
0.050
Why?
Cytoskeleton
1
1999
4
0.050
Why?
Infectious Disease Transmission, Vertical
1
1999
28
0.040
Why?
Medically Uninsured
1
2019
5
0.040
Why?
Premature Birth
1
2019
6
0.040
Why?
Australia
1
2019
9
0.040
Why?
Netherlands
1
2019
4
0.040
Why?
Regression Analysis
1
2018
56
0.040
Why?
Metabolic Diseases
1
2018
13
0.040
Why?
Polymorphism, Single Nucleotide
1
2020
342
0.040
Why?
Practice Patterns, Nurses'
1
2017
5
0.040
Why?
Bacterial Outer Membrane Proteins
1
2017
1
0.040
Why?
beta-Lactam Resistance
1
2017
1
0.040
Why?
Fimbriae Proteins
1
2017
1
0.040
Why?
Penicillin-Binding Proteins
1
2016
2
0.040
Why?
Pharmacy Service, Hospital
1
2016
8
0.040
Why?
Practice Patterns, Physicians'
1
2017
85
0.040
Why?
Sequence Homology
1
2015
2
0.040
Why?
Evolution, Molecular
1
2015
3
0.040
Why?
Genome, Viral
1
2015
4
0.040
Why?
China
1
2015
8
0.040
Why?
Colorado
1
2015
8
0.030
Why?
Dyspnea
1
2015
5
0.030
Why?
Respiratory Sounds
1
2015
6
0.030
Why?
Cough
1
2015
7
0.030
Why?
Respiration, Artificial
1
2015
17
0.030
Why?
Emergency Medical Services
1
2015
14
0.030
Why?
Primary Health Care
1
2015
44
0.030
Why?
Clinical Laboratory Services
1
2015
2
0.030
Why?
Economics, Hospital
1
2015
3
0.030
Why?
Sexually Transmitted Diseases
1
2015
9
0.030
Why?
Cost Savings
1
2015
10
0.030
Why?
High-Throughput Nucleotide Sequencing
1
2015
100
0.030
Why?
Gene Frequency
1
2015
88
0.030
Why?
Program Evaluation
1
2015
52
0.030
Why?
Sexual Behavior
1
2015
40
0.030
Why?
Drainage
1
2013
37
0.030
Why?
Rats, Sprague-Dawley
2
2005
87
0.030
Why?
Rats
2
2005
155
0.030
Why?
Ambulatory Care
1
2013
46
0.030
Why?
Diagnostic Test Approval
1
2011
1
0.030
Why?
Tympanic Membrane
1
2011
1
0.030
Why?
Prosthesis Failure
1
2011
2
0.030
Why?
Administration, Topical
1
2011
6
0.030
Why?
United States Food and Drug Administration
1
2011
6
0.030
Why?
Otitis Media with Effusion
1
2011
3
0.030
Why?
Administration, Oral
1
2011
62
0.030
Why?
Recurrence
1
2011
123
0.030
Why?
Cell Wall
1
2010
1
0.020
Why?
Mycolic Acids
1
2010
1
0.020
Why?
Pigments, Biological
1
2010
1
0.020
Why?
Chaperonin 60
1
2010
1
0.020
Why?
DNA, Ribosomal Spacer
1
2010
2
0.020
Why?
Enzyme Stability
1
2010
3
0.020
Why?
DNA-Directed RNA Polymerases
1
2010
2
0.020
Why?
Africa
1
2010
3
0.020
Why?
Enzymes
1
2010
5
0.020
Why?
Temperature
1
2010
10
0.020
Why?
Hot Temperature
1
2010
3
0.020
Why?
Binding Sites
2
2002
28
0.020
Why?
Bacterial Adhesion
2
1999
2
0.020
Why?
Face
1
2008
3
0.020
Why?
Cefoxitin
1
2006
1
0.020
Why?
Doxycycline
1
2006
1
0.020
Why?
Hydroxyurea
1
2006
1
0.020
Why?
Linezolid
1
2006
2
0.020
Why?
Ciprofloxacin
1
2006
3
0.020
Why?
Acetamides
1
2006
2
0.020
Why?
Oxazolidinones
1
2006
2
0.020
Why?
Clarithromycin
1
2006
3
0.020
Why?
Mycobacterium fortuitum
1
2006
2
0.020
Why?
Amikacin
1
2006
3
0.020
Why?
Drug Therapy, Combination
1
2006
41
0.020
Why?
Uterine Diseases
1
2005
1
0.020
Why?
Gene Expression Regulation, Bacterial
1
2005
1
0.020
Why?
Structure-Activity Relationship
1
2002
6
0.010
Why?
Models, Molecular
1
2002
14
0.010
Why?
Protein Structure, Tertiary
1
2002
14
0.010
Why?
Mutagenesis, Site-Directed
1
2002
19
0.010
Why?
DNA, Kinetoplast
1
2002
1
0.010
Why?
Antibodies
1
2002
15
0.010
Why?
Antibodies, Protozoan
1
2002
3
0.010
Why?
Protein Binding
1
2002
30
0.010
Why?
Repetitive Sequences, Nucleic Acid
1
2002
3
0.010
Why?
B-Lymphocytes
1
2002
23
0.010
Why?
Gene Expression
1
2002
67
0.010
Why?
Blood Group Antigens
1
2001
1
0.010
Why?
Oligonucleotides
1
2001
4
0.010
Why?
Intestinal Diseases
1
2001
4
0.010
Why?
Hemagglutinins
1
2001
1
0.010
Why?
Pregnancy Complications, Infectious
1
2001
26
0.010
Why?
Terminology as Topic
1
2001
14
0.010
Why?
Neisseria gonorrhoeae
1
1999
1
0.010
Why?
Complement C1q
1
1999
3
0.010
Why?
Cattle
1
1999
25
0.010
Why?
Actins
1
1999
5
0.010
Why?
Recombinant Proteins
1
1999
49
0.010
Why?
Cytochalasin D
1
1997
1
0.010
Why?
Nocodazole
1
1997
1
0.010
Why?
Microscopy, Electron
1
1997
4
0.010
Why?
Immunohistochemistry
1
1997
46
0.010
Why?
Selvarangan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Physical Neighbors Expand Description
_